Home Facial Treatments Study Shows Potential Anti-Aging Benefits of Diabetes Drug Metformin Improve Covid-19 Mortality Rate

Study Shows Potential Anti-Aging Benefits of Diabetes Drug Metformin Improve Covid-19 Mortality Rate

Study Shows Potential Anti-Aging Benefits of Diabetes Drug Metformin Improve Covid-19 Mortality Rate


(MENAFN – GetNews)

Longevity therapies, specifically the potential anti-aging benefits of the diabetes drug Metformin, can help individuals survive COVID-19. Several studies suggest the drug can potentially help older adults who have a significantly higher COVID-19 mortality rate. AgelessRx, an online telemedicine clinic specializing in anti-aging treatments and research, is moving forward with two (2) separate COVID-19 trials. The AgelessRX team believes that Metformin will result in better outcomes for acute COVID-19, as well as better recovery from the post-COVID syndrome. 

The death rate for older individuals as a result of COVID-19 is significantly higher than the rest of the population. Research has found that those over the age of 55, even when healthy, are 50 times more like to die from COVID-19 than a car accident. Likewise, older adults are also more likely to experience the long-term negative effects of COVID-19. This increase in vulnerability is due to the aging process and the weakening of physiological resilience. Ultimately, the aging process makes adults over the age of 50 more at risk. Research surrounding anti-aging solutions and diabetes drug Metformin has shown that it can potentially slow down onset of age-related damage. 

In some studies, Metformin was shown to enhance the physiology and resiliency of the immune system as well as increase health spans, which is needed when fighting COVID-19. When an individual takes Metformin, longevity pathways are activated which in theory should help improve COVID-19 mortality rates Although more research and trials are to be conducted, this is a promising discovery.  

AgelessRX is spearheading the research on Metformin and COVID-19. As experts in anti-aging therapies and advocates for the adoption of treatments that effectively reverse age-related damage, which is the same damage that makes older adults more vulnerable to COVID-19. AgelessRX has received Institutional Review Board (IRB) approval for two (2) COVID-19 trials. In these separate trials, they will evaluate Metformin anti-aging therapies for acute COVID-19 infection as well as ‘post-COVID,’ also known as a long-COVID syndrome. 

AgelessRX hopes that these two trials will lead to better acute outcomes and ultimately reduce the mortality rate. Additionally, they hope that Metformin and LDN will be able to help individuals who are still suffering from the long-term effects of the virus and heal faster. A reduction in mortality rates and an increase in complete recovery from post-COVID syndrome will free up other medical resources and provide a more affordable and accessible treatment option. 

AgelessRX invites those interested in following these trials’ results to visit their website for more information. Visitors will find a number of resources and current research on Metformin and other anti-aging therapies as well as their prescription services. 

About AgelessRx

AgelessRx (www.agelessrx.com) is an online telemedicine clinic that specializes in anti-aging. The online platform specializes in products that slow down the accumulation of age-related damage. AgelessRx services allow patients to get Doctor-assisted care and personally prescribed products like NAD+, Metformin, and LDN from the comfort of their homes. 

Media Contact
Company Name: AgelessRx
Contact Person: Anar Isman
Email: Send Email
Phone: 650-503-9990
Address: 835 Mason ste 250
City: Dearborn
State: MI
Country: United States


Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.


Source link